Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019
Open Access
- 1 August 2019
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (8) , 1067-1073
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Immunotherapy of Hepatocellular Carcinoma: Facts and HopesClinical Cancer Research, 2018
- Immunological landscape and immunotherapy of hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2015
- Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodiesInternational Immunology, 2014
- Immunotherapy of Hepatocellular CarcinomaHepatic Oncology, 2014
- Inflammation lights the way to metastasisNature, 2014
- Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular CarcinomaHepatology, 2013
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- CTLA-4 Control over Foxp3 + Regulatory T Cell FunctionScience, 2008
- Hepatocellular carcinoma: Recent trends in the United StatesGastroenterology, 2004
- Inflammation and cancerNature, 2002